Search Images Maps Play YouTube News Gmail Drive More »
Sign in
Screen reader users: click this link for accessible mode. Accessible mode has the same essential features but works better with your reader.

Patents

  1. Advanced Patent Search
Publication numberUS3788315 A
Publication typeGrant
Publication dateJan 29, 1974
Filing dateApr 20, 1971
Priority dateApr 20, 1971
Publication numberUS 3788315 A, US 3788315A, US-A-3788315, US3788315 A, US3788315A
InventorsS Laurens
Original AssigneeS Laurens
Export CitationBiBTeX, EndNote, RefMan
External Links: USPTO, USPTO Assignment, Espacenet
Disposable cutaneous transjector
US 3788315 A
Abstract
A disposable cutaneous transjecting device is formed of a cylindrically shaped housing having an open end closed by a cover securely attached to the housing. The housing forms a chamber divided by a piston plunger into a subchamber for a liquid medication and another subchamber containing means, such as a compressed gas or a spring member, for displacing the piston plunger and forcing the medication through capillary openings in the cover. Prior to use the means are restrained from displacing the piston plunger. A removable cap forms a seal for the cover. On the exterior of the housing a trigger or similar member is located for releasing the means so that the piston plunger is displaced toward the cover and the medication is ejected through the openings in the cover.
Images(1)
Previous page
Next page
Claims  available in
Description  (OCR text may contain errors)

United States Patent [191 Laurens 1 1 DISPOSABLE CUTANEOUS TRANSJECTOR Jan. 29, 1974 Primary ExaminerRichard A. Gaudet Assistant Examiner-G. F. Dunne Attorney, Agent, or FirmToren and McGeady [5 7 ABSTRACT A disposable cutaneous transjecting device is formed of a cylindrically shaped housing having an open end closed by a cover securely attached to the housing. The housing forms a chamber divided by a piston plunger into a subchamber for a liquid medication and another subchamber containing means, such as a compressed gas or a spring member, for displacing the piston plunger and forcing the medication through capillary openings in the cover. Prior to use the means are restrained from displacing the piston plunger. A removable cap forms a seal for the cover. On the exterior of the housing a trigger or similar member is located for releasing the means so that the piston plunger is displaced toward the cover and the medication is ejected through the openings in the cover.

12 Claims, 7 Drawing Figures PAIENTEDMzsmn INVENTOR.

57.5 [was/vs F IG. 3

IIIM FIG. I

Maw?

1 DISPOSABLE CUTANEOUS TRANSJECTOR SUMMARY OF THE INVENTION The present invention is directed to a disposable cutaneous transjecting device and, more particularly, it concerns a relatively small-sized device with a trigger mechanism on its exterior surface for releasing the means which eject the medication from the device under high pressure and velocity.

For some time various devices have been available for the transcutaneous administration of liquid medicaments which replace the usual subcutaneous injection by hypodermic syringe and needle. In such devices liquid medications are administered by forcing fine streams of the liquid, under high pressure, through the dermal tissues. Presently, two different types of devices are available, one the gun type and the other the manual Dermojet type.

The gun type is a heavy-duty, cumbersome apparatus which is approximately the size of an electric hand drill. It is not portable and is connected through tubing to a compressed-gas cylinder. Basically, the gun type is useful in mass-inoculations, such as in the Armed Services and for field-vaccinations in epidemics. Its main disadvantages are its size, weight, and lack of mobility. Further, there have been indications that painful skin lacerations have occurred during its use which may have resulted from faulty handling or from excessive pressure used in operating the device.

The manual Dermojet type of device is about the size and shape of a large foutain pen or pocket flashlight and is a rather expensive instrument. In this type of device the power source is either a small compressed gas cylinder or a powerful spring mechanism. The Dermojet type is disadvantageous in that it involves rather tedious modes of application and reuse. The exact amount of the injectable medication has to be tanked prior to each usage and the springmechanism has to be cocked before each time the medication is administered. Additionally, sterilization procedures have to be regularly performed to assure aseptic operation of the device.

The main advantages achieved by needleless injections are the relative painlessness of the administration of the medication and the absence of trauma previously created by the penetration of the skin tissues with the needle. Accordingly, any source of infection or bleeding resulting from the insertion of the needle is avoided. Further, from a psychological point of view needleless injections are of considerable benefit to patients who are excessively apprehensive of injections.

Therefore, the primary object of the present invention is to provide a small lightweight device for the transcutaneous introduction of liquid medicaments which can be easily manipulated with one hand or only three fingers. Preferably, the device can be inexpensively produced for disposable usage.

Another object of the invention is to provide a completely sterilized device which meets all the requirements for the administration of medications under the strictest rules of asepsis.

Yet another object of the invention is to provide a choice of power sources for the device, that is either the use of compressed gas or of a spring mechanism.

Still another object of the invention is to provide an arrangement containing a premeasured dosage of a medication ready for administration with the medication being readily identifiable by the use of labels applied to the exterior of the device. The time saved in the administration of a premeasured amount of medication could be of life-saving importance in certain emergencies.

Therefore, in accordance with the present invention, a cutaneous transjecting device is provided which includes an elongated housing, preferably cylindrical in shape, and open at one end for the introduction of the power source and the liquid medication. The open end of the housing is closed by a cover member which can be secured in place in various ways. Small diameter capillary passageways are provided through the cover member so that the liquid medication can be forced out under very high pressure. The housing and its cover member form a chamber which is divided by a piston plunger into a pair of subchambers or spaces, one containing the liquid medication and the other containing the power source. The power source, either compressed gas or a spring mechanism, is retained in the chamber for release by a trigger-like mechanism. When the device is to be used, the trigger-like mechanism is actuated and the power source displaces the piston plunger toward the cover member with the liquid medication being forced out through the openings in the cover at such high pressure and velocity that it is capable of passing through the dermal tissues for subcutaneous administration. It should be noted that the present device affords a replacement for subcutaneous injections, however, it cannot be used to replace intramuscular or intravenous injections.

As a disposable device containing a premeasured amount of liquid medication, a removable seal member or cap is provided over the cover member through which the capillary openings pass so that sterile conditions are maintained and there is no possibility of leakage from the chamber.

When compressed gas is used as the power source it is contained within one end of the chamber and the trigger-like mechanism is formed of an elongated rodlike member which is displaceable through the chamber transversely of its elongated direction. The rod-like member has an opening formed through it which can be aligned with an opening into the space containing the compressed gas for releasing the gas when the transjection of the medication is to be effected. If a spring mechanism is used as the power source, it is held in a compressed or cocked position by a clip device and by pressing the clip device on the exterior of the housing the spring is released and drives the piston plunger against the liquid medication forcing it through the openings in the cover member.

By means of the present invention it is possible to provide exactly premeasured dosages of a medication in a sterile condition ready for use merely by removing the seal or cap from the cover on the housing. With the medication being premeasured and the sterile conditions maintained, the problems of human error experienced in the use of conventional hypodermic syringes are overcome to a considerable degree.

There are many potential usages for the device embodying the present invention, for example, it is particularly useful in private practice, hospitals and dentistry, especially for pediatric usage, in emergency kits of various kinds (field medicine), in the personal administration of insulin by diabetics, in the administration of presurgical local anesthesia, and in the intralesional administration of cortico-steroids in dermatology.

The various features of novelty which characterize the invention are pointed out with particularity in the claims annexed to and forming a part of this disclosure. For a better understanding of the invention, its operating advantages and specific objects attained by its use, reference should be had to the accompanying drawings and descriptive matter in which there are illustrated and described preferred embodiments of the invention.

BRIEF DESCRIPTION OF THE DRAWING In the drawing:

FIG. 1 is a perspective view, approximately to scale, of a transjecting device embodying the present invention;

FIG. 2 is a partial perspective view of the device shown in FIG. 1, illustrating the end through which the liquid medication is administered;

FIG. 3 is an enlarged longitudinal sectional view of the device in FIG. 1 with the power source in the retained position;

FIG. 4 is a view of the member employed in FIG. 3 for retaining the power source;

FIG. 5 is a view. similar to FIG. 3 with the device in position for transjecting the liquid medication and with the member of FIG. 4 displaced for releasing the power source;

FIG. 6 is a partial sectional view taken at right angles to the section shown in FIG. 3; and

FIG. 7 is a sectional view, similar to FIG. 3, showing another form of power source in accordance with the present invention.

DETAILED DESCRIPTION OF THE INVENTION- In the drawing a cutaneous transjector l is shown which is formed of an elongated housing 3 closed at one end and open at its opposite end, preferably the housing is cylindrical in shape with smoothly rounded edges. At its open end the housing 3 is closed by a cover member 5 which, as shown in FIG. 3, is secured by means of a threaded engagement with the housing. The combination of the housing 3 and cover member 5 form an elongated chamber 7 within the transjector l. A plurality of openings 9 extend through the cover member 5 communicating between the chamber 7 and the exterior of the device.

As shown in FIG. 2, a tensor ring 1 1 is formed on and extends about the radially outer end face surface of the cover member encircling the portion containing the openings 9. The tensor ring 11 has a corrugated or roughened surface which aids in keeping the injection site taut and in preventing slippage during administration of the medication.

In the embodiment of the invention shown in FIGS. 3 and 5, a transverse partition wall 13 extends across the chamber 7 intermediate its ends and divides the chamber into subchambers or spaces 7a, 7b, with the space 7a adjacent the cover member arranged to contain the liquid medication and the other space 7b arranged to contain the power source, in the form of a compressed gas, for ejecting the liquid medication.

' Within the space 7a a piston plunger 15 is provided which is displaceable through the space by the power source for forcing the liquid medication through the openings 9 in the cover member 5. As shown in FIGS.

the transversely displaceable member through the chamber and its opening 17a registers with 3 and 5, the inner and outer surfaces of the cover member 5 which register with the space 7a, have a curved configuration, that is the outer surface of the cover member has a convex shape while the inner surface has a concave shape. Similarly, the end surface of the piston plunger closer to the cover member has a convex shape which is provided to approximate the meniscus of the liquid medication to be ejected from the transjector.

The partition wall 13 between the spaces and 7b has an opening through which the compressed gas is released against the piston plunger when the liquid medication is administered. To retain the compressed gas within the space 7b a trigger-like member 17 extends across the end of the space 7a remote from the cover plate and in contact with the surface of the partition wall 13. The trigger-like member is transversely displaceable across the chamber 7 and is provided with an opening or bore 17a which can be moved into registration with the opening 13a in the partition wall for releasing the compressed gas against the piston plunger 15.

Alternatively, to increase the frictional engagement of the trigger-like member 17 it can be arranged to pass through the partition wall instead of in contact with only one of its faces.

In FIG. 3, the transversely displaceable member 17 is shown with its opening 17a laterally displaced from the opening 13a in the partition wall 13 so that the compressed gas is retained within the space 7b. In this position a triggering element or release button 17b formed on the outer end of the member is spaced outwardly from the housing 3. At its opposite end, the trigger-like member 17 has a nail-head safety element which prevents it from being displaced laterally out of the housing in the direction of the release button 17b. Initially, a piece of tape 19, for instance a medication and dosage label, or similar means is provided over the nailhead safety element 170 so that the trigger-like member cannot be accidentally displaced and release the power source. On the trigger-like member 17, spaced from the release button 17b so that it is located within the walls of the housing 3, is a annular shaped part 17d which provides frictional engagement with the housing to assure that a positive displacing action or force is exerted against the release button 17b before 17 moves the opening 13a in the partition wall 13.

In FIG. 1 a removable seal or protective cap 21 is provided over the end of the device containing the openings 9. Preferably, the protective cap is formed of soft polyethylene material which is easily removable for uncovering the end face of the cover member which is applied to the transjection site when the device is to be used. Further, other seal members presently available could be used in place of the soft polyethylene cap.

In FIG. 6 the trigger-like member 17 is shown in a plane normal to that in FIG. 3 with its upper surface in engagement with the lower surface of the partition wall 13 so that a positive seal is provided about the opening 13a to assure that compressed gas does not leak from the space 7b into contact with the surface of the piston plunger 15.

In FIG. 7 another embodiment of the invention is shown with a spring member 2 being used as the power source in place of the compressed gas. Similar parts in the embodiments shown in FIGS. 3 and 7 have the same reference numerals. Intermediate the ends of the chamber 7 support elements 23 extend radially inwardly and provide displaceable abutments against which the spring member 2 seats when it is held in its retained position. A clip-type trigger member 25 is accessible on the exterior of the housing 3 and when the triggering member is pushed inwardly on the opposite sides of the housing the support elements 23 are displaced outwardly releasing the spring member 2 so that it forces the piston plunger toward the cover member 5 and ejects the liquid medication filled into the chamber through the openings 9. Safety means can be incorporated into the triggering member 25 so that it cannot be accidentally actuated for releasing the spring mechanism.

Principally the transjecting device is intended for disposable use and for such use would be constructed of a tough, firm plastic, such as Nylon, Vinyl and the like, which have sufficient strength to contain the power sources without distortion and to avoid any fracture or bending when the power source is released and the liquid medication discharged from the chamber. Furthermore, the material used should be chemically inert to avoid any alteration in the chemical structure of the liquid medication contained in the device. In addition, the material used must be capable of maintaining its effectiveness during sterilization. A silicon treated medication chamber could ease the propulsion step considerably.

As mentioned above, the transjecting device in accordance with the present invention is primarily intended for disposable use and can be operated with one hand or by only using three fingers. An example of the size of the device is as follows: the housing is cylindrical being 4 to 5cm in length and 1.5 to 2 cm in diameter. The application or proximal end, the end which contacts the skin in administering the medication, is slightly convex and contains four to eight openings each having a diameter of approximately 1 to 2 mm in order to facilitate the passage of micro-crystalline and precipitate solutions. The opposite end of the housing is flat. At the proximal end and surrounding the convexly shaped portion is the tensor ring having a width in the radial direction of approximately 2 to 3mm and having a roughened or corrugated configuration which aids in keeping the transjection side taut and in preventing any slippage during administration of the medication. In the embodiment shown in FIG. 3, with the trigger-like member 17 in position for retaining the power source the release button 17b is spaced outwardly from the housing a distance equal to the offset of the opening 17a in the member 17 from the opening 13a in the partition wall 13. The walls of the housing 3 and the cover member 5 are between 2 and 4 mm in thickness leaving sufficient room within the chamber formed by the housing and cover member for the power source and the liquid medication.

The triggering mechanisms used for the different power sources must have sufficient resistance to applied pressure to avoid any premature or accidental discharge of the medication. A built-in friction factor in the material forming the mechanism would provide an additional safety measure.

To facilitate the assembly of the transjecting device 1 its chamber 7 is formed by the housing 3 and the separate cover member 5. Initially, the power source is supplied into the chamber and held in the retained position, then, after the insertion of the piston plunger 15, a premeasuredamount of the liquid medication is charged into the chamber and the cover member 5 is secured to the housing so that a liquid tight seal is provided. As an alternative, the length of the cover member 5 could be increased so that the premeasured dosage of medication is filled into the cover member and is closed by inserting the piston plunger 15 into the cover member, then the cover member could be attached to the housing 3. Various types of seals can be used, for instance, as shown in FIGS. 3 and 5 a threaded closure can be used, further the cover member and housing can be thermally fused together, note FIG. 7, or a bayonet type closure can be employed. Due to the capillary nature of the openings 9 through the cover member 5 there should be no leakage through the openings. In addition, to maintain sterile conditions at the proximal end of the device which is applied to the skin area during the administration of the medication, a removal seal member, such as a soft polyethylene type cap, is fitted over the end of the transjecting device during storage, note FIG. 1.

In another embodiment the premeasured dosages of medication could be supplied in containers formed by the cover member 5 and the piston plunger 15 and then attached to a member such as the housing 3 containing the power source prior to use.

When the device such as shown in FIG. 1 is ready for use, the seal 1 is removed from the cover member and the tape 19 or other safety means is removed from the end of the trigger-like member 17 which releases the power source. In FIG. 3 the seal 21 has been removed, however, the tape 19 which restrains the trigger-like member 17 from transverse displacement is still in position. In FIG. 5 the tape is shown at least partly removed from the housing with the trigger-like member 17 pushed laterally through the housing so that its hole 17a aligns with the opening 13a through the partition wall 13 and the compressed gas power source expands from the space 7b and exerts considerable pressure against the piston plunger 15 driving it toward the cover member 5. As the piston plunger is displaced by the compressed gas, due to the laws of hydraulics, the liquid medication is forced at very high pressures and velocity through the openings 9 in the cover member and will pass in very fine streams through the cutaneous tissues providing the transjection of the liquid medication without the use of any needle and in a manner which is almost completely painless and without trauma.

While specific embodiments of the invention have been shown and described in detail to illustrate the application of the inventive principles, it will be understood that the invention may be embodied otherwise without departing from such principles.

What is claimed is:

l. A disposable cutaneous transjecting device comprising a self-contained manually operable transjector, said transjector comprising an elongated housing open at one end and closed at the other end and forming a chamber within said housing, a cover member secured to the open end of said housing and providing a closure for said chamber therein, said cover member having at least one small diameter capillary passageway therethrough in its surface extending across the open end of said housing and said passageway communicating between said chamber and the exterior surface of said cover member, a piston plunger fitted within said chamber for displacement therein in the axial direction of said housing extending between its ends and said pis ton plunger dividing said chamber into a pair of spaces with the one of said spaces adjacent said cover member arranged to contain a liquid medicament therein,

means within the other one of said spaces for displacing said piston plunger toward said cover member, manually actuatable means accessible on the exterior of said housing for retaining said means from displacing said piston plunger and for releasing said means for displacing said piston plunger through the one of said spaces toward said cover member so that the liquid medicament contained in said one of said spaces is displaced therefrom through said passageway in said cover member, a removable seal member fitted over the exterior surface of said cover member containing said passageway for preventing contamination, said means within the other one of said spaces for displacing said piston plunger comprises a quantity of compressed gas, said actuatable means comprises a partition wall extending transversely of the elongated direction of said housing and located on the opposite side of said piston plunger from said cover member, said partition wall having an opening therethrough for admitting the compressed gas into contact with said piston plunger, and a transversely displaceable member arranged to seal the opening in said partition wall and having an opening therethrough which is registerable with the opening in said partition wall for releasing said compressed gas into contact with said piston plunger for discharging the medicament from said device, whereby said device is usable as a disposable element containing a required dosage of a medicament ready for transjection upon the removal of said seal member.

2. A cutaneous transjecting device, as set forth in claim 1, characterized in that said transversely displaceable member comprising an elongated rod-like member extending through said housing from one side to the. other with the opening being provided therethrough, a release element provided on one end of said rod-like member so that when said rod-like member is positioned to retain said means from displacing said plunger said release element is positioned outwardly from the outer surface of said housing and when said rod-like member is moved through said housing said release element is displaced toward said housing and acts as a stop preventing said rod-like member from further passage through said housing and the opening through said rod-like member is aligned with the opening in said partition wall and admits the compressed gas to said piston plunger for ejecting the medication from the one of said spaces adjacent said cover member.

3. A cutaneous transjecting device, as set forth in claim 2, characterized in that said rod-like member having an annular protuberance formed thereon and acting as a safety element for preventing accidental displacement of said rod-like member through said housing, said protuberance being in contact with the walls forming said housing when said rod-like member is in position for retaining said compressed gas from displacing said piston plunger.

4. A cutaneous transjecting device, as set forth in claim 2, characterized in that removable means are attached to the exterior of said housing on the opposite end of said rod-like member from said release element and are arranged to prevent said rod-like member from being movably displaced through said housing.

5. A cutaneous transjecting device, as set forth in claim 1, characterized in that the exterior surface of said cover in alignment with said chamber is convex.

6. A cutaneous transjecting device, as set forth in claim 5, characterized in that the inner surface and the outer surface of said cover member are in substantially parallel relationship and the surface of said piston plunger closer to said cover member having a convex configuration approximating the meniscus of the liquid medication to be contained within the one of said spaces forming said chamber.

7. A cutaneous transjecting device, as set forth in claim 1, characterized in that said cover member having screw threads formed thereon and said housing having similar screw threads thereon adjacent its open end for effecting threaded engagement between said cover and said housing.

8. A cutaneous transjecting device, as set forth in claim 1, characterized in that said cover member being arranged to fit over the end of said housing and is thermally fused to said housing.

9. A cutaneous transjecting device, as set forth in claim 5, characterized in that the radially outer suface of the end exterior face of said cover member encircling the convexly shaped surface of said cover member containing and passageways having alternating ridges and valleys forming a roughened surface for avoiding slippage of said device when applied to the transjecting side and for maintaining the transjecting side taut.

10. A cutaneous transjecting device, as set forth in claim 9, characterized in that said alternating ridges and valleys extending radially on the end face of said cover member have a width in the radial direction of approximately 2 to 3 mm.

11. A cutaneous transjecting device, as set forth in claim 1, characterized in that said removable seal member is formed of a soft polyethylene material.

12. A cutaneous transjecting device, as set forth in claim 1, wherein said housing is cylindrically shaped and is formed of a lightweight plastic material, said housing being approximately 4 to 5 cm in length and 1.5 to 2 cm in diameter and the walls of said housing being in the range of 2 to 4 mm in thickness, and the openings in said cover member being approximately 1 to 2 mm in diameter.

Patent Citations
Cited PatentFiling datePublication dateApplicantTitle
US2380534 *Mar 15, 1943Jul 31, 1945Lockhart Marshall LHypodermic injector
US2605763 *Jan 31, 1948Aug 5, 1952Becton Dickinson CoInjection device
US2800903 *Sep 4, 1953Jul 30, 1957Becton Dickinson CoInjection apparatus
*DE957598A Title not available
Referenced by
Citing PatentFiling datePublication dateApplicantTitle
US3977401 *Mar 25, 1975Aug 31, 1976William Floyd PikeInjection apparatus
US3977402 *Jul 14, 1975Aug 31, 1976William Floyd PikeInjection apparatus and method with automatic aspiration feature
US4680027 *Dec 12, 1985Jul 14, 1987Injet Medical Products, Inc.Needleless hypodermic injection device
US4913699 *Mar 14, 1988Apr 3, 1990Parsons James SDisposable needleless injection system
US4926859 *Dec 4, 1986May 22, 1990Field John EA medical treatment device for treating an undesired formation in a living body
US5024656 *Aug 30, 1988Jun 18, 1991Injet Medical Products, Inc.Gas-pressure-regulated needleless injection system
US5026343 *Nov 17, 1989Jun 25, 1991Walter HolzerDevice for needleless hypodermic injection of medications
US5074843 *Nov 3, 1989Dec 24, 1991Tino DaltoDevice for subcutaneous injection without a needle
US5470311 *May 24, 1994Nov 28, 1995The United States Of America As Represented By The Secretary Of The ArmyMicrosphere drug application device
US5499972 *Sep 29, 1993Mar 19, 1996Equidyne Systems, Inc.Hypodermic jet injector
US5569189 *Apr 14, 1995Oct 29, 1996Equidyne Systems, Inc.hypodermic jet injector
US5630796 *Jun 7, 1995May 20, 1997Oxford Biosciences LimitedMethod of delivering powder transdermally with needless injector
US5643211 *Feb 29, 1996Jul 1, 1997Medi-Ject CorporationNozzle assembly having a frangible plunger
US5697917 *Feb 29, 1996Dec 16, 1997Medi-Ject CorporationNozzle assembly with adjustable plunger travel gap
US5704911 *Dec 8, 1995Jan 6, 1998Equidyne Systems, Inc.Needleless hypodermic jet injector
US5722953 *Feb 29, 1996Mar 3, 1998Medi-Ject CorporationNozzle assembly for injection device
US5800388 *Feb 29, 1996Sep 1, 1998Medi-Ject CorporationPlunger/ram assembly adapted for a fluid injector
US5840061 *May 14, 1996Nov 24, 1998Ferton HoldingEjection apparatus for the high pressure ejection of a liquid
US5865795 *Feb 29, 1996Feb 2, 1999Medi-Ject CorporationSafety mechanism for injection devices
US5875976 *Dec 24, 1996Mar 2, 1999Medi-Ject CorporationLocking mechanism for nozzle assembly
US5899879 *Dec 19, 1995May 4, 1999Genesis Medical Technologies, Inc.Spring-actuated needleless injector
US5899880 *Jun 7, 1995May 4, 1999Powderject Research LimitedNeedleless syringe using supersonic gas flow for particle delivery
US5921967 *Dec 24, 1996Jul 13, 1999Medi-Ject CorporationPlunger for nozzle assembly
US5954232 *Aug 1, 1996Sep 21, 1999The Boc Group PlcGas delivery system
US6010478 *Aug 14, 1997Jan 4, 2000Powderject Research LimitedTrans-mucosal particle delivery
US6013050 *Apr 24, 1997Jan 11, 2000Powderject Research LimitedParticle delivery
US6074360 *Jul 21, 1997Jun 13, 2000Boehringer Mannheim GmbhElectromagnetic transdermal injection device and methods related thereto
US6083197 *Oct 1, 1998Jul 4, 2000Umbaugh; Jerald C.Spring-actuated needleless injector
US6168587Dec 5, 1997Jan 2, 2001Powderject Research LimitedNeedleless syringe using supersonic gas flow for particle delivery
US6210359Jan 21, 2000Apr 3, 2001Jet Medica, L.L.C.Needleless syringe
US6217911Jul 5, 1996Apr 17, 2001The United States Of America As Represented By The Secretary Of The Armysustained release non-steroidal, anti-inflammatory and lidocaine PLGA microspheres
US6410056May 22, 1995Jun 25, 2002The United States Of America As Represented By The Secretary Of The ArmyChemotherapeutic treatment of bacterial infections with an antibiotic encapsulated within a biodegradable polymeric matrix
US6447796Aug 21, 1997Sep 10, 2002The United States Of America As Represented By The Secretary Of The ArmySustained release hydrophobic bioactive PLGA microspheres
US6475181 *Jul 3, 1998Nov 5, 2002Powderject Research LimitedDrug particle delivery
US6528097Nov 20, 2000Mar 4, 2003The United States Of America As Represented By The Secretary Of The ArmySustained release non-steroidal, anti-inflammatory and lidocaine PLGA microspheres
US6592545Mar 15, 1999Jul 15, 2003Powderject Research LimitedParticle delivery
US6623446Jun 30, 2000Sep 23, 2003CrossjectNeedleless syringe comprising an injector with stacked elements
US6626871Oct 10, 2000Sep 30, 2003Felton International, Inc.Method and apparatus for removing cap from medical device
US6676630Jun 4, 2002Jan 13, 2004Bioject Medical Technologies, Inc.Needle-free injection system
US6685669Dec 21, 1995Feb 3, 2004Powderject Research LimitedParticle delivery
US6770054Nov 21, 2000Aug 3, 2004Felton International, Inc.Injector assembly with driving means and locking means
US6802826Oct 10, 2000Oct 12, 2004Felton International, Inc.Universal anti-infectious protector for needleless injectors
US6844010Jul 18, 2000Jan 18, 2005The United States Of America As Represented By The Secretary Of The ArmyTherapeutic treatment and prevention of infections with a bioactive materials encapsulated within a biodegradable-biocompatible polymeric matrix
US6855331Jun 10, 2002Feb 15, 2005The United States Of America As Represented By The Secretary Of The ArmySustained release hydrophobic bioactive PLGA microspheres
US6883222Oct 16, 2002Apr 26, 2005Bioject Inc.Drug cartridge assembly and method of manufacture
US6890319Aug 13, 1999May 10, 2005Imprint Pharmaceuticals Ltd.Apparatus for delivering a substance having one or more needles driven at high velocity
US6902743Apr 6, 1998Jun 7, 2005The United States Of America As Represented By The Secretary Of The ArmyTherapeutic treatment and prevention of infections with a bioactive material(s) encapuslated within a biodegradable-bio-compatable polymeric matrix
US6911015Dec 18, 2000Jun 28, 2005CrossjectNeedleless syringe functioning by shock-tube effect, with prior lateral retention of the active principle
US6939546Jan 26, 1998Sep 6, 2005The United States Of America As Represented By The Secretary Of The ArmyModel for testing immunogenicity of peptides
US6981961Jun 30, 2000Jan 3, 2006CrossjectNeedleless syringe comprising an injector with nested elements
US7033608Jun 22, 1999Apr 25, 2006The United States Of America As Represented By The Secretary Of The Army“Burst-free” sustained release poly-(lactide/glycolide) microspheres
US7056300 *Jan 26, 2001Jun 6, 2006CrossjectNeedleless syringe for injecting a liquid contained in a prefilled ampule
US7074210Oct 11, 2002Jul 11, 2006Felton International, Inc.Universal protector cap with auto-disable features for needle-free injectors
US7207967Feb 13, 1997Apr 24, 2007Powderject Research LimitedParticle delivery
US7238167Jan 13, 2004Jul 3, 2007Bioject Inc.Needle-free injection system
US7261702Jun 30, 2000Aug 28, 2007CrossjectNeedleless syringe operating with an impact wave generator through a wall
US7513885 *May 20, 2004Apr 7, 2009CrossjectNeedleless syringe with membrane isolating a multiple duct injector
US7604811Dec 10, 1996Oct 20, 2009The United States Of America As Represented By The Secretary Of The ArmyOral-intestinal vaccines against diseases caused by enteropathic organisms using antigens encapsulated within biodegradable-biocompatible microspheres
US7618393Nov 13, 2006Nov 17, 2009Pharmajet, Inc.Needle-less injector and method of fluid delivery
US7618394 *Dec 9, 2002Nov 17, 2009Powderject Research LimitedNeedleless syringe using supersonic gas flow for particle delivery
US7699802May 3, 2005Apr 20, 2010Pharmajet, Inc.Needle-less injector
US7833189Feb 13, 2006Nov 16, 2010Massachusetts Institute Of TechnologyControlled needle-free transport
US7887506Nov 21, 2000Feb 15, 2011Pulse Needlefree Systems, Inc.Safety mechanism to prevent accidental patient injection and methods of same
US7942846Aug 31, 2007May 17, 2011Powderject Research LimitedNeedleless syringe using supersonic gas flow for particle delivery
US8061006Jul 25, 2002Nov 22, 2011Powderject Research LimitedParticle cassette, method and kit therefor
US8118777May 26, 2010Feb 21, 2012Cook Medical Technologies LlcSystems and methods for delivering therapeutic agents
US8172790Aug 31, 2007May 8, 2012Massachusetts Institute Of TechnologyNeedle-free injector device with autoloading capability
US8328755Oct 18, 2010Dec 11, 2012Massachusetts Institute Of TechnologyControlled needle-free transport
US8361054Dec 8, 2009Jan 29, 2013Cook Medical Technologies LlcApparatus and methods for containing and delivering therapeutic agents
US8398583Sep 10, 2010Mar 19, 2013Massachusetts Institute Of TechnologyMethod and apparatus for extraction of a sample from a sample source
US8529500Jun 16, 2011Sep 10, 2013Pharmajet, Inc.Needle-less injector and method of fluid delivery
US8728032Jan 17, 2012May 20, 2014Cook Medical Technologies LlcSystems and methods for delivering therapeutic agents
US8992466Dec 7, 2012Mar 31, 2015Massachusetts Institute Of TechnologyControlled needle-free transport
USRE40786Jun 2, 2000Jun 23, 2009The United States Of America As Represented By The Secretary Of The ArmyVaccines against intracellular pathogens using antigens encapsulated within biodegradable-biocompatible microspheres
USRE41157Nov 30, 1999Mar 2, 2010The United States Of America As Represented By The Secretary Of The ArmyMicroparticle carriers of maximal uptake capacity by both M cells and non-M cells
CN101128230BFeb 10, 2006Sep 29, 2010麻省理工学院Surface injection device
DE19955201A1 *Nov 16, 1999May 31, 2001Roesch Ag MedizintechnikInjektionseinrichtung
EP0000610A1 *Jul 20, 1978Feb 7, 1979THE PROCTER & GAMBLE COMPANYMethod and apparatus for spraying a metered quantity of a semi-liquid product
EP0317298A2 *Nov 16, 1988May 24, 1989Sy-Quest International LimitedImproved apparatus for hypodermic injection of liquids
EP0367677A1 *Nov 3, 1989May 9, 1990Tino DaltoDevice for subcutaneous needle-less injection
EP0370571A2 *Nov 17, 1989May 30, 1990Holzer, Walter, Senator h.c. Dr.h.c.Ing.Device for needle-less subcutaneous medicament injection
EP0404818A1 *Mar 10, 1989Jan 2, 1991James Stuart ParsonsDisposable needleless injection system.
EP0757202A2 *Jul 23, 1996Feb 5, 1997The BOC Group plcGas delivery system
EP1635896A1 *Jun 17, 2004Mar 22, 2006Allergan, Inc.Needless injectors
EP1637173A2 *Apr 8, 1994Mar 22, 2006PowderJect Research LimitedParticle delivery
EP2018871A1Feb 19, 1999Jan 28, 2009MetaMorphix International, Inc.Immunological methods to modulate myostatin in vertebrate subjects
EP2295075A1Jan 3, 2002Mar 16, 2011University Of SaskatchewanEnterohemorragic escherichia coli vaccine
WO1987003468A1 *Dec 4, 1986Jun 18, 1987John Edwin FieldMedical treatment device
WO1990004989A1 *Nov 3, 1989May 17, 1990Tino DaltoSub-cutaneous injection device without a needle
WO1994007554A1 *Sep 28, 1993Apr 14, 1994Equidyne Systems IncHypodermic jet injector
WO1994024263A1 *Apr 8, 1994Oct 27, 1994Oxford Biosciences LtdNeedleless syringe using supersonic gas flow for particle delivery
WO1998032397A1Jan 20, 1998Jul 30, 1998Biostar IncPharmaceutical delivery system
WO1999044658A1 *Mar 3, 1999Sep 10, 1999Dalto TinoDevice for hypodermic injection without needle of a medicine in liquid form
WO2001005453A1 *Jun 30, 2000Jan 25, 2001Alexandre PatrickNeedleless syringe comprising an injector with stacked elements
WO2001005454A1 *Jun 30, 2000Jan 25, 2001Alexandre PatrickNeedleless syringe comprising an injector with nested elements
WO2001047585A1 *Dec 18, 2000Jul 5, 2001Patrick AlexandreNeedleless syringe operating by impact tube effect, with prior lateral retention of active principle
WO2004112871A1 *Jun 17, 2004Dec 29, 2004Allergan IncNeedless injectors
WO2006086719A1 *Feb 10, 2006Aug 17, 2006Massachusetts Inst TechnologySurface injection device
WO2006086742A2 *Feb 9, 2006Aug 17, 2006Al Kenany SaadMicrostream injector
Classifications
U.S. Classification604/70
International ClassificationA61M5/30, A61M5/20
Cooperative ClassificationA61M5/30, F17C2270/0736, A61M5/2053
European ClassificationA61M5/30